Dr. Reddy's Laboratories Ltd. (DRREDDY)

Compare with another name

Dr. Reddy's Laboratories Ltd. (DRREDDY) reported consolidated revenue from operations of ₹8,100 crore for Q1 FY2027, the quarter ended 30 June 2026, down 5.5% on the same quarter a year earlier. Profit after tax was ₹436 crore, down 69.1% on the year, and earnings per share ₹5.33. The figures are the company's own, from the un-audited results it filed with NSE on 22 July 2026.

The public record on DRREDDY

Quarterly results, the last 12 quarters

₹ crore except per share, consolidated, as filed with the exchange. Operating profit is sales less the expenses other than interest and depreciation, OPM is that over sales, and tax % is tax over profit before tax: arithmetic on the filed lines; everything else is as filed. Quarters before December 2024 are from the exchange's earlier results feed, which carries the filed lines without the filing itself; the column links to the exchange's page for the company. EPS is as filed for each quarter. A split or a bonus issue changes the share count, so quarters before it are on the old count.

Profit and loss, 10 fiscal years and the trailing twelve months

₹ crore except per share, consolidated, from the audited results for each year, linked. Operating profit, OPM and tax % are arithmetic on the filed lines. TTM is the sum of the last four quarters.

Balance sheet at year end

From the statement of assets and liabilities in the audited fourth-quarter filing, which the exchange carries from FY2025; the TTM column is the latest half-year or year-end statement. Borrowings, investments and cash each add the current and non-current lines as filed.

Cash flows

From the cash flow statement in the audited fourth-quarter filing, which the exchange carries from FY2025. Free cash flow is cash from operations less the purchase of fixed assets, arithmetic on the two filed lines.

EPS is as filed for each year. A split or a bonus issue changes the share count, so years before it are on the old count.

Compounded growth

Compounded growth is the latest fiscal year over the year that many years earlier, annualised; the TTM column is the last four quarters over the four before. Return on equity is net profit over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the owners' equity from the balance sheet, or paid-up capital plus reserves where the older feed carries only those. Arithmetic on filed numbers, nothing forecast.

Segments, Q1 FY2027

Segment revenue and segment result as the company filed them, before inter-segment eliminations; share and result over revenue are arithmetic on those.

Shareholding pattern

Percentages are of the total share count, as the company filed them under Regulation 31. Encumbered is the part of the promoters' own holding that is pledged, under a non-disposal undertaking or otherwise encumbered. All domestic institutions includes mutual funds, insurers, banks, pension funds and AIFs. Retail is resident individuals holding up to ₹2 lakh of nominal capital. Each row links to the filing.

The shareholding pattern, quarter by quarter, on its own page

Peers: Healthcare

The names on this site in the same industry (the exchange's industry for the index), by market capitalisation. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close.

Filings